We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleOral administration of GW788388, an inhibitor of TGF-β type I and II receptor kinases, decreases renal fibrosisAuthorsPetersen, M.; Thorikay, M.; Deckers, M.; van Dinther, M.; Grygielko, E.T.; Gellibert, F.; de Gouville, A.C.; Huet, S.; ten Dijke, P.; Laping, N.J.PublicationKidney International, 2008, Vol 73, Issue 6, p705ISSN0085-2538Publication typearticleDOI10.1038/sj.ki.5002717